Homology Medicines Inc (NAS:FIXX)
$ 0.9347 0.0071 (0.77%) Market Cap: 3.02 Mil Enterprise Value: -78.32 Mil PE Ratio: 0 PB Ratio: 0.04 GF Score: 32/100

Homology Medicines Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript

Oct 13, 2021 / 12:15AM GMT
Release Date Price: $111.6 (-5.63%)
Arthur Tzianabos
Homology Medicines, Inc. - Chairman

Thank you. Good afternoon, everybody. It's a really good crowd considering the number of people I saw at the bar on the way over here. It's great to be here again, and update you on the progress we've made at Homology Medicines over the last year to two years now. Forward looking statements, I'm glad we can skip by that slide. It's not [reg] FD.

When I come to the Mesa, I really see the crystallization of genetic medicines and the ability now to actually talk about curing diseases, versus a world that we've been in for a long time where you can only treat a disease. So this is what really drives us and everybody here in the room at Homology in terms of being able to treat and potentially cure patients living with rare genetic disorders.

So Homology is a fully integrated company with a dual platform for gene therapy, and in-vivo gene editing. The technology really involves 15 novel AAV capsids that were isolated from human stem cells. And as an immunologist I really like that profile because it would lead you to believe that there is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot